One Enzyme Emerges as Master Switch for Building Fast Peripheral Nerves

In the crowded world of molecular biology, where hundreds of signaling proteins compete for attention, it is rare for a single enzyme to stand out as indispensable. Yet a new study published in Cellular and Molecular Life Sciences argues exactly that for adenyl cyclase 6, or Adcy6, an enzyme that generates the ubiquitous intracellular messenger cyclic adenosine monophosphate, better known as cAMP. According to a team led by Marcel Tawk at Université Paris-Saclay and INSERM, Adcy6 acts as an evolutionarily conserved master regulator of peripheral nerve development, orchestrating the timely myelination of axons by Schwann cells in vertebrates. The finding, published open access on 2 October 2026, reshapes how scientists understand the earliest molecular events that allow nerves to conduct electricity at speed.

Myelination is one of the most elegant tricks in biology. In the peripheral nervous system, Schwann cells wrap themselves around large-caliber axons in multiple spiral layers of membrane, forming an insulating sheath that allows electrical impulses to leap between gaps called the nodes of Ranvier, where clusters of sodium channels reignite the signal. Without this insulation, impulses crawl; with it, they race. The process depends on precise timing: Schwann cells must proliferate, sort individual axons from bundles, differentiate, and only then begin wrapping. Decades of in vitro work had suggested that cAMP, a classic second messenger, drives Schwann cell proliferation and differentiation, but the identity of the enzyme that actually produces cAMP in living animals, and its full role in nerve development, had remained stubbornly unknown.

To find that missing regulator, the researchers combined pharmacological, genetic, molecular, and live-imaging approaches in two vertebrate systems: zebrafish and mice. Zebrafish larvae are transparent, which allowed the team to watch peripheral nerves develop in real time under the microscope, while mice provided a mammalian counterpart for physiological validation. The answer that emerged was Adcy6, one of nine membrane-bound adenyl cyclase isoforms in vertebrates, each of which converts ATP into cAMP in response to different upstream signals. In zebrafish, loss of Adcy6 disrupted the timely radial sorting of axons and delayed myelination in the peripheral nervous system, without altering the distribution or proliferation of Schwann cells along the nerves. That distinction is critical: the enzyme is not needed to put Schwann cells in the right place, but to tell them when to start building myelin.

The study also clarified where Adcy6 sits in a well-known signaling cascade. A G-protein-coupled receptor called Gpr126 has long been recognized as essential for Schwann cell myelination, but the steps between receptor activation and myelin gene expression were incompletely mapped. The new data show that Adcy6 is the main driver of early Gpr126 signaling, positioned upstream of protein kinase A, or PKA, the enzyme that cAMP activates and that ultimately switches on myelin genes. In other words, when Gpr126 fires during development, it is Adcy6 that translates that signal into the cAMP burst that PKA needs to initiate the myelination program on schedule. This places a specific adenyl cyclase isoform, rather than a generic pool of cAMP, at the head of one of the most important developmental pathways in the peripheral nervous system.

Mammals added a twist. In mice, the researchers found that Adcy6 works in synergy with a related isoform, Adcy5, to fulfill the same function. Mice engineered to lack both Adcy6 and Adcy5 displayed excess mortality, severe tremor, reduced nerve size, defective nerve conduction, and motor dysfunction. Electrophysiological and anatomical analyses revealed both axonal and glial defects, indicating that the consequences of losing these enzymes extend beyond the wrapping cells themselves to the neurons whose axons they insulate. The tremor and motor impairment are exactly what one would expect from peripheral nerves that fail to transmit signals efficiently, and the reduced survival underscores how fundamental this pathway is to viable nerve function.

Perhaps the most surprising part of the story is that Adcy6 is not merely a glial enzyme. The team provided evidence that Adcy6 regulates neuronal numbers, mediates axonal transport, and, acting autonomously within neurons, influences the clustering of sodium channels at the nodes of Ranvier. Node formation is a cooperative feat between axons and myelinating glia, and the new results suggest that the cAMP-generating machinery inside neurons helps determine where and how the ion channels that regenerate the action potential assemble. A single adenyl cyclase isoform thus touches nearly every layer of peripheral nerve construction: the survival of neurons, the movement of materials along axons, the differentiation of Schwann cells, and the electrical architecture of the mature nerve.

From an evolutionary standpoint, the conservation of this mechanism is striking. Zebrafish and mice diverged hundreds of millions of years ago, yet in both species the same enzyme family member governs the timing of peripheral myelination. This deep conservation implies that the Adcy6-centered cAMP pathway was already embedded in the vertebrate developmental toolkit before the major lineages split, and that evolution has preserved it because the timing of myelination is too important to leave to redundant systems. The partial redundancy observed in mice, where Adcy5 can compensate alongside Adcy6, suggests a layered system in which one isoform dominates early signaling while a close relative provides backup, a configuration that may buffer development against genetic or environmental perturbation.

The technical achievement behind these conclusions deserves emphasis. Live imaging in zebrafish allowed the authors to distinguish between defects in Schwann cell migration, proliferation, and differentiation, disentangling processes that are usually conflated in fixed tissue. Pharmacological manipulation of cAMP levels, combined with genetic loss-of-function models and a constitutively active PKA construct, helped establish the ordering of the pathway from Gpr126 through Adcy6 to PKA and finally to myelin gene expression. In mice, the availability of Adcy5 and Adcy6 knockout animals, acknowledged from collaborators at Oslo University Hospital, enabled the double-mutant analysis that revealed the synergistic requirement and the dramatic physiological consequences of removing both enzymes.

The clinical implications are tantalizing, even if the study is fundamentally basic science. Congenital and inherited peripheral neuropathies often involve defective myelination, and understanding the master timing switch for the myelination program could eventually point to therapeutic targets. If the cAMP-PKA axis controlled by Adcy6 could be modulated pharmacologically, it might in principle be possible to nudge Schwann cells toward myelination in disorders where the process is delayed or stalled. The finding that Adcy6 also affects neuronal survival and axonal transport adds further relevance, since many neuropathies involve secondary axonal degeneration. The authors note no competing interests, and the work was funded by the AFM, Inserm, and Université Paris-Saclay, with the article published under a Creative Commons open access license.

For now, the study’s chief contribution is conceptual: it replaces a vague notion of diffuse cAMP signaling with a concrete, named molecular actor at the top of the peripheral myelination cascade. Adenyl cyclase 6, long one of nine relatively anonymous isoforms, is now positioned as the chief regulator that vertebrates rely on to build fast, properly insulated peripheral nerves on schedule. As the authors conclude, their findings identify Adcy6 as a primary driver of early and timely cAMP activity in vivo during peripheral nervous system development. Future work will likely explore how Gpr126 activates Adcy6 specifically, why Adcy5 can only partially substitute in mammals, and whether the same pathway can be harnessed to repair nerves after injury, questions that could keep this enzyme at the center of neurobiology for years to come.

Subject of Research: The role of adenyl cyclase 6 in cAMP signaling during peripheral nerve development and myelination

Article Title: Adenyl cyclase 6 is an evolutionary conserved chief regulator of peripheral nerve development and timely myelination in vertebrates

Article References: El-Hage, O., Boueid, M.-J., Magné, F., Echaniz-Laguna, A., Melki, J., Degerny, C., & Tawk, M. (2026). Adenyl cyclase 6 is an evolutionary conserved chief regulator of peripheral nerve development and timely myelination in vertebrates. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06443-3

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06443-3

Keywords: Adcy6, Adcy5, cAMP, Schwann cells, myelination, peripheral nervous system, Gpr126, PKA, zebrafish, mice, nodes of Ranvier, nerve development